169 related articles for article (PubMed ID: 9102740)
21. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.
Jensen DM; Pace SC; Soffer E; Comer GM;
Am J Gastroenterol; 2006 Sep; 101(9):1991-9; quiz 2170. PubMed ID: 16968504
[TBL] [Abstract][Full Text] [Related]
22. Rapid improvement of symptomatology with pantoprazole, amoxycillin and metronidazole in Helicobacter pylori-positive duodenal ulcer patients.
Pilotto A; Leandro G; Franceschi M; Bierti L; Di Battista R; Notarbartolo A; Pisciotta G; Grassi A; Crestani B; Tafner G; Michelagnoli S; Garotta F
Hepatogastroenterology; 1999; 46(25):245-51. PubMed ID: 10228801
[TBL] [Abstract][Full Text] [Related]
23. A review of treatment of duodenal and gastric ulcers--pantoprazole vs. omeprazole.
Schepp W; Rehner M; Witzel L
Aliment Pharmacol Ther; 1994; 8 Suppl 1():53-7. PubMed ID: 8180295
[TBL] [Abstract][Full Text] [Related]
24. [The action of the proton pump inhibitor pantoprazol against acetylsalicylic acid-induced gastroduodenopathy in comparison to ranitidine. An endoscopic controlled, double blind comparison].
Müller P; Simon B
Arzneimittelforschung; 1998 May; 48(5):482-5. PubMed ID: 9638315
[TBL] [Abstract][Full Text] [Related]
25. Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicenter study.
Koop H; Schepp W; Dammann HG; Schneider A; Lühmann R; Classen M
J Clin Gastroenterol; 1995 Apr; 20(3):192-5. PubMed ID: 7797824
[TBL] [Abstract][Full Text] [Related]
26. Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. The International Pantoprazole HP Study Group.
Adamek RJ; Bethke TD
Am J Gastroenterol; 1998 Oct; 93(10):1919-24. PubMed ID: 9772056
[TBL] [Abstract][Full Text] [Related]
27. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
Russo A; Dattilo M
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
[TBL] [Abstract][Full Text] [Related]
28. The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H. pylori eradication and duodenal ulcer healing.
Sivri B; Simsek I; Hulagu S; Kadayifci A; Tozun N; Akarsu M; Uraz S; Savas MC; Koruk M; Bozbas A
Curr Med Res Opin; 2004 Aug; 20(8):1301-7. PubMed ID: 15324533
[TBL] [Abstract][Full Text] [Related]
29. Prevention of erosive oesophagitis relapse with pantoprazole.
Richter JE; Fraga P; Mack M; Sabesin SM; Bochenek W;
Aliment Pharmacol Ther; 2004 Sep; 20(5):567-75. PubMed ID: 15339328
[TBL] [Abstract][Full Text] [Related]
30. Comparison of pantoprazole versus omeprazole in the treatment of acute duodenal ulceration--a multicentre study.
Rehner M; Rohner HG; Schepp W
Aliment Pharmacol Ther; 1995 Aug; 9(4):411-6. PubMed ID: 8527617
[TBL] [Abstract][Full Text] [Related]
31. Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine.
Hawkey CJ; Long RG; Bardhan KD; Wormsley KG; Cochran KM; Christian J; Moules IK
Gut; 1993 Oct; 34(10):1458-62. PubMed ID: 8244121
[TBL] [Abstract][Full Text] [Related]
32. Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole.
Takeuchi K; Konaka A; Nishijima M; Kato S; Yasuhiro T
J Gastroenterol Hepatol; 1999 Mar; 14(3):251-7. PubMed ID: 10197495
[TBL] [Abstract][Full Text] [Related]
33. Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care.
Talley NJ; Moore MG; Sprogis A; Katelaris P
Med J Aust; 2002 Oct; 177(8):423-7. PubMed ID: 12381251
[TBL] [Abstract][Full Text] [Related]
34. Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis.
Metz DC; Bochenek WJ;
Aliment Pharmacol Ther; 2003 Jan; 17(1):155-64. PubMed ID: 12492745
[TBL] [Abstract][Full Text] [Related]
35. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P
Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
[TBL] [Abstract][Full Text] [Related]
36. Omeprazole heals duodenal, but not gastric ulcers more rapidly than ranitidine. Results of two German multicentre trials.
Classen M; Dammann HG; Domschke W; Hüttemann W; Londong W; Rehner M; Simon B; Witzel L; Berger J
Hepatogastroenterology; 1985 Oct; 32(5):243-5. PubMed ID: 3908262
[TBL] [Abstract][Full Text] [Related]
37. In treatment of active duodenal ulcer and Helicobacter pylori eradication.
Yukselen V; Yasa MH; Karaoglu AO
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cccvi-cccviii. PubMed ID: 15244210
[TBL] [Abstract][Full Text] [Related]
38. Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
Brunner G; Harke U
Aliment Pharmacol Ther; 1994; 8 Suppl 1():59-64. PubMed ID: 8180296
[TBL] [Abstract][Full Text] [Related]
39. Pantoprazole--a third proton pump inhibitor.
Drug Ther Bull; 1997 Dec; 35(12):93-4. PubMed ID: 9614720
[No Abstract] [Full Text] [Related]
40. Dose-range finding study with the proton pump inhibitor pantoprazole in acute duodenal ulcer patients.
Müller P; Simon B; Khalil H; Lühmann R; Leucht U; Schneider A
Z Gastroenterol; 1992 Nov; 30(11):771-5. PubMed ID: 1471382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]